Sartorius AG
Sartorius AG (SOAGY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
soagy · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Sartorius AG (SOAGY) measures how much investors pay for each dollar of the company's trailing earnings. SOAGY's current PE ratio of 101.99x is calculated by dividing its stock price of $56.06 by its TTM earnings per share of $2.36. −9.2% discount vs 5Y avg 112.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%226.8x
MedianQ3 · 75%1368.2x
Max
At 101.99x, SOAGY's current P/E is lower than in 5% of its annual fiscal year readings over the past 19 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Sartorius AGYou SOAGY | $81.9B | 101.99x | +268.6% | $2.36 |
 Chugai Pharmaceutical Co., Ltd. CHGCF | $77.2B | 32.63x | +17.9% | $263.96 |
 Chugai Pharmaceutical Co., Ltd. CHGCY | $77.4B | 29.80x | +7.7% | $138.26 |
 GSK plc GLAXF | $94.4B | 12.94x | -53.2% | $1.41 |
 HOYA Corporation HOCPF | $59.3B | 34.98x | +26.4% | $748.61 |
 HOYA Corporation HOCPY | $55.9B | 34.72x | +25.5% | $788.79 |
 Merck KGaA MKGAF | $69.4B | 20.95x | -24.3% | $6.00 |
Industry Average 6 peers with valid PE | — | 27.67x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 114.70x | $0.43 | -35.5% | |
2024-12-31 FY2024 | 177.79x | $0.24 | +59.2% | |
2023-12-31 FY2023 | 111.67x | $0.60 | +197.2% | |
2022-12-31 FY2022 | 37.57x | $1.98 | -68.6% | |
2021-12-31 FY2021 | 119.80x | $0.93 | +14.4% | |
2020-12-31 FY2020 | 104.76x | $0.61 | -41.0% | |
2019-12-31 FY2019 | 177.56x | $0.46 | -7.8% | |
2018-12-31 FY2018 | 192.50x | $0.41 | -15.0% | |
2017-12-31 FY2017 | 226.54x | $0.34 | -21.3% | |
2016-12-31 FY2016 | 287.86x | $0.30 | +26.9% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Sartorius AG (SOAGY) measures how much investors pay for each dollar of the company's trailing earnings. SOAGY's current PE ratio of 101.99x is calculated by dividing its stock price of $56.06 by its TTM earnings per share of $2.36.
Frequently asked questions
SOAGY pe ratio · 6 questionsSOAGY's current PE ratio is 101.99x as of 2026-06-09, based on a stock price of $56.06 and TTM EPS of $2.36. Data sourced from Financial Modeling Prep via SOAGY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Sartorius AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09